Literature DB >> 11116953

Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system.

C T Morita1, R A Mariuzza, M B Brenner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11116953     DOI： 10.1007/s002810000042

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  169 in total

Review 1.  Conformations of immunoglobulin hypervariable regions.

Authors:  C Chothia; A M Lesk; A Tramontano; M Levitt; S J Smith-Gill; G Air; S Sheriff; E A Padlan; D Davies; W R Tulip
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

2.  Recognition of a peptide antigen by heat shock--reactive gamma delta T lymphocytes.

Authors:  W Born; L Hall; A Dallas; J Boymel; T Shinnick; D Young; P Brennan; R O'Brien
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

3.  In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans.

Authors:  F Jouen-Beades; E Paris; C Dieulois; J F Lemeland; V Barre-Dezelus; S Marret; G Humbert; J Leroy; F Tron
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T cell clone.

Authors:  P Del Porto; M D'Amato; M T Fiorillo; L Tuosto; E Piccolella; R Sorrentino
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

5.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.

Authors:  H Jomaa; J Wiesner; S Sanderbrand; B Altincicek; C Weidemeyer; M Hintz; I Türbachova; M Eberl; J Zeidler; H K Lichtenthaler; D Soldati; E Beck
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

6.  Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.

Authors:  F Halary; M A Peyrat; E Champagne; M Lopez-Botet; A Moretta; L Moretta; H Vié; J J Fournié; M Bonneville
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

7.  Cytidine 5'-triphosphate-dependent biosynthesis of isoprenoids: YgbP protein of Escherichia coli catalyzes the formation of 4-diphosphocytidyl-2-C-methylerythritol.

Authors:  F Rohdich; J Wungsintaweekul; M Fellermeier; S Sagner; S Herz; K Kis; W Eisenreich; A Bacher; M H Zenk
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

8.  T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis.

Authors:  R Sciammas; P Kodukula; Q Tang; R L Hendricks; J A Bluestone
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

9.  CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.

Authors:  S Porcelli; C T Morita; M B Brenner
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

10.  Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms.

Authors:  M K Perera; R Carter; R Goonewardene; K N Mendis
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307
View more
  65 in total

1.  Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections.

Authors:  Yun Shen; Dejiang Zhou; Liyou Qiu; Xioamin Lai; Meredith Simon; Ling Shen; Zhongchen Kou; Qifan Wang; Liming Jiang; Jim Estep; Robert Hunt; Michelle Clagett; Prabhat K Sehgal; Yunyaun Li; Xuejun Zeng; Craig T Morita; Michael B Brenner; Norman L Letvin; Zheng W Chen
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

2.  Ab initio DFT study of bisphosphonate derivatives as a drug for inhibition of cancer: NMR and NQR parameters.

Authors:  Hussein Aghabozorg; Beheshteh Sohrabi; Sara Mashkouri; Hamid Reza Aghabozorg
Journal:  J Mol Model       Date:  2011-06-02       Impact factor: 1.810

3.  Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.

Authors:  Nichole L Bryant; G Yancey Gillespie; Richard D Lopez; James M Markert; Gretchen A Cloud; Catherine P Langford; Hilal Arnouk; Yun Su; Hilary L Haines; Catalina Suarez-Cuervo; Lawrence S Lamb
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

Review 4.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 5.  Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

6.  Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.

Authors:  Matthias Eberl; Hassan Jomaa; Adrian C Hayday
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 8.  [Immunology of tuberculosis: impact on the development of novel vaccines].

Authors:  T Ulrichs; S H E Kaufmann
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

Review 9.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

10.  FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia.

Authors:  Daniel M Schreeder; Jicun Pan; Fu Jun Li; Eric Vivier; Randall S Davis
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.